{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:45:48Z","timestamp":1789721148890,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"clinical research special project of Shanghai First Maternity and Infant Hospital","award":["2023B16"],"award-info":[{"award-number":["2023B16"]}]},{"name":"Shanghai Science and Technology Innovation Action Plan","award":["22S31903700"],"award-info":[{"award-number":["22S31903700"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203999"],"award-info":[{"award-number":["82203999"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To assess the utility of clinical and MRI features in distinguishing ovarian clear cell carcinoma (CCC) from adnexal masses with ovarian-adnexal reporting and data system (O-RADS) MRI scores of 4\u20135.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective study included 850 patients with indeterminate adnexal masses on ultrasound. Two radiologists evaluated all preoperative MRIs using the O-RADS MRI risk stratification system. Patients with O-RADS MRI scores of 4\u20135 were divided into a training set (<jats:italic>n<\/jats:italic>\u2009=\u2009135, hospital A) and a test set (<jats:italic>n<\/jats:italic>\u2009=\u200986, hospital B). Clinical and MRI features were compared between CCC and non-CCC patients. Analysis of variance and support vector machine were used to develop four CCC prediction models. Tenfold cross-validation was applied to determine the hyperparameters. Model performance was evaluated by the area under the curve (AUC) and decision curve.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>221 patients were included (30 CCCs, 191 non-CCCs). CA125, HE4, CEA, ROMA, endometriosis, shape, parity, unilocular, component, the growth pattern of mural nodules, high signal on T1WI, number of nodules, the ratio of signal intensity, and the ADC value were significantly different between CCCs and non-CCCs. The kappa and interobserver correlation coefficient of each MRI feature exceeded 0.85. The comprehensive model combining clinical and MRI features had a greater AUC than the clinical model and tumour maker model (0.92 vs 0.66 and 0.78 in the test set; both <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), displaying improved net benefit.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The comprehensive model combining clinical and MRI features can effectively differentiate CCC from adnexal masses with O-RADS MRI scores of 4\u20135.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Critical relevance statement<\/jats:title>\n            <jats:p>CCC has a high incidence rate in Asians and has limited sensitivity to platinum chemotherapy. This comprehensive model improves CCC prediction ability and clinical applicability for facilitating individualised clinical decision-making.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key Points<\/jats:title>\n            <jats:p>\n              <jats:list list-type=\"bullet\">\n                <jats:list-item>\n                  <jats:p>Identifying ovarian CCC preoperatively is beneficial for treatment planning.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Ovarian CCC tends to be high-signal on T1WI, unilocular, big size, with endometriosis and low CEA.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>This model, integrating clinical and MRI features, can differentiate ovarian CCC from adnexal masses with O-RADS MRI scores 4\u20135.<\/jats:p>\n                <\/jats:list-item>\n              <\/jats:list>\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13244-024-01860-z","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T17:57:41Z","timestamp":1738173461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The value of MRI in differentiating ovarian clear cell carcinoma from other adnexal masses with O-RADS MRI scores of 4\u20135"],"prefix":"10.1186","volume":"16","author":[{"given":"Lingling","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6619-335X","authenticated-orcid":false,"given":"Jiejun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"1860_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17\u201348","journal-title":"CA Cancer J Clin"},{"key":"1860_CR2","doi-asserted-by":"publisher","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","volume":"20","author":"DK Armstrong","year":"2022","unstructured":"Armstrong DK, Alvarez RD, Backes FJ et al (2022) NCCN guidelines\u00ae insights: ovarian cancer, version 3.2022. J Natl Compr Canc Netw 20:972\u2013980","journal-title":"J Natl Compr Canc Netw"},{"key":"1860_CR3","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","volume":"88","author":"T Sugiyama","year":"2000","unstructured":"Sugiyama T, Kamura T, Kigawa J et al (2000) Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88:2584\u20132589","journal-title":"Cancer"},{"key":"1860_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jamaoncol.2023.0197","volume":"9","author":"DL Richardson","year":"2023","unstructured":"Richardson DL, Eskander RN, O\u2019Malley DM (2023) Advances in ovarian cancer care and unmet treatment needs for patients with platinum resistance: a narrative review. JAMA Oncol 9:851\u2013859","journal-title":"JAMA Oncol"},{"key":"1860_CR5","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00330-016-4533-x","volume":"27","author":"Y Kurata","year":"2017","unstructured":"Kurata Y, Kido A, Moribata Y et al (2017) Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour. Eur Radiol 27:1695\u20131703","journal-title":"Eur Radiol"},{"key":"1860_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-016-0251-x","volume":"9","author":"FH Ma","year":"2016","unstructured":"Ma FH, Qiang JW, Zhang GF, Li HM, Cai SQ, Rao YM (2016) Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma. J Ovarian Res 9:40","journal-title":"J Ovarian Res"},{"key":"1860_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0497-1","volume":"12","author":"S Morioka","year":"2019","unstructured":"Morioka S, Kawaguchi R, Yamada Y, Iwai K, Yoshimoto C, Kobayashi H (2019) Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary. J Ovarian Res 12:20","journal-title":"J Ovarian Res"},{"key":"1860_CR8","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s00261-020-02571-x","volume":"46","author":"M Li","year":"2021","unstructured":"Li M, Tan J, Zhang Y, Ai C, Wang H, Zhang H et al (2021) Assessing CT imaging features comprehensive with CEA and CA125 levels to identify endometriosis-associated ovarian cancer. Abdom Radiol (NY) 46:2367\u20132375","journal-title":"Abdom Radiol (NY)"},{"key":"1860_CR9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1007\/s11547-023-01666-x","volume":"128","author":"J Ren","year":"2023","unstructured":"Ren J, Mao L, Zhao J et al (2023) Seeing beyond the tumour: computed tomography image-based radiomic analysis helps identify ovarian clear cell carcinoma subtype in epithelial ovarian cancer. Radiol Med 128:900\u2013911","journal-title":"Radiol Med"},{"key":"1860_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jacr.2020.12.022","volume":"18","author":"C Reinhold","year":"2021","unstructured":"Reinhold C, Rockall A, Sadowski EA et al (2021) Ovarian-adnexal reporting lexicon for MRI: a white paper of the ACR ovarian-adnexal reporting and data systems MRI committee. J Am Coll Radiol 18:713\u2013729","journal-title":"J Am Coll Radiol"},{"key":"1860_CR11","doi-asserted-by":"publisher","first-page":"e1919896","DOI":"10.1001\/jamanetworkopen.2019.19896","volume":"3","author":"I Thomassin-Naggara","year":"2020","unstructured":"Thomassin-Naggara I, Poncelet E, Jalaguier-Coudray A et al (2020) Ovarian-adnexal reporting data system magnetic resonance imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses. JAMA Netw Open 3:e1919896","journal-title":"JAMA Netw Open"},{"key":"1860_CR12","doi-asserted-by":"publisher","first-page":"W280","DOI":"10.2214\/AJR.10.4706","volume":"196","author":"RM El Kady","year":"2011","unstructured":"El Kady RM, Choudhary AK, Tappouni R (2011) Accuracy of apparent diffusion coefficient value measurement on PACS workstation: a comparative analysis. AJR Am J Roentgenol 196:W280\u2013W284","journal-title":"AJR Am J Roentgenol"},{"key":"1860_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-021-00941-7","volume":"15","author":"T Wang","year":"2022","unstructured":"Wang T, Wang H, Wang Y et al (2022) MR-based radiomics-clinical nomogram in epithelial ovarian tumour prognosis prediction: tumour body texture analysis across various acquisition protocols. J Ovarian Res 15:6","journal-title":"J Ovarian Res"},{"key":"1860_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155\u2013163","journal-title":"J Chiropr Med"},{"key":"1860_CR15","doi-asserted-by":"publisher","first-page":"e0237587","DOI":"10.1371\/journal.pone.0237587","volume":"15","author":"Y Song","year":"2020","unstructured":"Song Y, Zhang J, Zhang YD et al (2020) FeAture explorer (FAE): a tool for developing and comparing radiomics models. PLoS One 15:e0237587","journal-title":"PLoS One"},{"key":"1860_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.acra.2022.06.007","volume":"30","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Wang H, Li Q, Sun H, Guo L (2023) Discriminating between benign and malignant solid ovarian tumours based on clinical and radiomic features of MRI. Acad Radiol 30:814\u2013822","journal-title":"Acad Radiol"},{"key":"1860_CR17","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","volume":"318","author":"AC Alba","year":"2017","unstructured":"Alba AC, Agoritsas T, Walsh M et al (2017) Discrimination and calibration of clinical prediction models: users\u2019 guides to the medical literature. JAMA 318:1377\u20131384","journal-title":"JAMA"},{"key":"1860_CR18","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","volume":"74","author":"B Van Calster","year":"2018","unstructured":"Van Calster B, Wynants L, Verbeek JFM et al (2018) Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol 74:796\u2013804","journal-title":"Eur Urol"},{"key":"1860_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ajpath.2020.09.006","volume":"191","author":"IM Shih","year":"2021","unstructured":"Shih IM, Wang Y, Wang TL (2021) The origin of ovarian cancer species and precancerous landscape. Am J Pathol 191:26\u201339","journal-title":"Am J Pathol"},{"key":"1860_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejrad.2018.10.021","volume":"109","author":"HL Joo","year":"2018","unstructured":"Joo HL, Shin YR, Rha SE, Park CS, Shim DJ, Kim K (2018) Preoperative discrimination of tumour stage in clear cell carcinoma of the ovary using computed tomography and magnetic resonance imaging. Eur J Radiol 109:19\u201326","journal-title":"Eur J Radiol"},{"key":"1860_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216057","volume":"555","author":"RL Hollis","year":"2023","unstructured":"Hollis RL (2023) Molecular characteristics and clinical behaviour of epithelial ovarian cancers. Cancer Lett 555:216057","journal-title":"Cancer Lett"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-024-01860-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T17:57:49Z","timestamp":1738173469000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-024-01860-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1860"],"URL":"https:\/\/doi.org\/10.1186\/s13244-024-01860-z","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board approval was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This retrospective study was approved by the institutional review board with the waiver of the informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"One of the authors (L.C.) is an employee of Shanghai United Imaging Intelligence. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}